02). “The FDA’s acceptance of our New Drug Application takes us another step closer to bringing relacorilant to patients with hypercortisolism,” said Joseph Belanoff, MD, Corcept’s Chief ...

“The FDA’s acceptance of our New Drug Application takes us another step closer to bringing relacorilant to patients with hypercortisolism,” said Joseph Belanoff, M.D., Corcept’s Chief Executive ...

Tottenham Hotspur and Manchester City confirm their starting lineups for tonight's Premier League clash in North London. Haaland has missed the Citizens' last two matches with a knee injury and ...

I'll now turn the call over to Joe Belanoff, our Chief Executive Officer. Joe? Thank you, Charlie, and thank you, everyone, for joining us this afternoon. 2024 was a great year for Corcept.

Belanoff, M.D., Corcept’s Chief Executive Officer. Corcept’s fourth quarter 2024 revenue was $181.9 million, compared to $135.4 million in the fourth quarter of 2023. Revenue for the full year ...

Phil Foden has sent Manchester City fans a fresh update as the team prepares for a crucial showdown against Tottenham in the Premier League. Pep Guardiola’s side will be looking to bounce back ...

We are confident that our Cushing’s syndrome business will grow for many years,” said Joseph K. Belanoff, M.D., Corcept’s Chief Executive Officer. Corcept’s fourth quarter 2024 revenue was $181.9 ...

Phil Foden was ready to take over the world. A potential was finally fulfilled last season, the ghost of David Silva laid to rest at long last. In the same season, it wasn’t that Dominik ...

Another tough week for Manchester City and for arguably the greatest player in their history. De Bruyne showed he was still capable of the odd great ball, yet he lost the ball too often for ...

Michael Regan/Getty ImagesReal Madrid and Bayern Munich have emerged as potential suitors for Phil Foden, following reports of Guardiola’s willingness to consider a sale. Since making his senior debut ...